5a13be122b
Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>
80 lines
4.6 KiB
Markdown
80 lines
4.6 KiB
Markdown
---
|
|
type: "Bill"
|
|
title: "Opioids - As enacted, clarifies that a physician licensed in this state is the only healthcare provider authorized to prescribe a buprenorphine product for a FDA-approved use in recovery or medication-assisted treatment; revises criteria for providers not licensed in this state to prescribe a buprenorphine product for the treatment of opioid use disorder. - Amends TCA Title 33; Title 41; Title 53 and Title 63."
|
|
description: "Opioids - As enacted, clarifies that a physician licensed in this state is the only healthcare provider authorized to prescribe a buprenorphine product for a FDA-approved use in recovery or medication-assisted treatment; revises criteria for providers not licensed in this state to prescribe a buprenorphine product for the treatment of opioid use disorder. - Amends TCA Title 33; Title 41; Title 53 and Title 63."
|
|
jurisdiction: "us/states/tn"
|
|
legislature: "Tennessee General Assembly"
|
|
session: "114"
|
|
identifier: "HB 1239"
|
|
citation: "Tennessee HB 1239 (114)"
|
|
classification: ["bill"]
|
|
subjects: ["Opioids"]
|
|
status: "enacted"
|
|
primary_sponsors: ["Helton-Haynes"]
|
|
version_count: 3
|
|
action_count: 27
|
|
vote_count: 0
|
|
first_action: "2025-02-06"
|
|
last_action: "2025-04-28"
|
|
source: "openstates"
|
|
source_identifier: "ocd-bill/7b282135-c886-44b0-bad3-76758bbbc006"
|
|
source_url: "https://wapp.capitol.tn.gov/apps/BillInfo/Default?BillNumber=HB1239&ga=114"
|
|
source_hash: "0265be448a415688bf6207011a56286d7a093402ed1028a9d9307dcf4005a3d6"
|
|
vintage: "2026-07-01"
|
|
source_snapshot: "https://data.openstates.org/daily/2026-07-01/public.pgdump"
|
|
retrieved_at: "2026-07-06"
|
|
confidence: "reported"
|
|
tags: ["legislation", "bill", "us-tn"]
|
|
---
|
|
|
|
# Tennessee HB 1239 (114) — Opioids - As enacted, clarifies that a physician licensed in this state is the only healthcare provider authorized to prescribe a buprenorphine product for a FDA-approved use in recovery or medication-assisted treatment; revises criteria for providers not licensed in this state to prescribe a buprenorphine product for the treatment of opioid use disorder. - Amends TCA Title 33; Title 41; Title 53 and Title 63.
|
|
|
|
## Version chain
|
|
|
|
The bill's text revisions, in order — the diff chain from filing to enrollment.
|
|
|
|
1. **Amendment HA0252** (committee substitute) — [source](https://capitol.tn.gov/Bills/114/Amend/HA0252.pdf)
|
|
2. **Amendment SA0095** (committee substitute) — [source](https://capitol.tn.gov/Bills/114/Amend/SA0095.pdf)
|
|
3. **Current Version** (committee substitute) — [source](https://capitol.tn.gov/Bills/114/Bill/HB1239.pdf)
|
|
|
|
## Sponsors
|
|
|
|
- Helton-Haynes — primary (person)
|
|
|
|
## Timeline
|
|
|
|
The legislative action history — every referral, reading, and vote.
|
|
|
|
- **2025-02-06** Filed for introduction `filing`
|
|
- **2025-02-10** Intro., P1C. `introduction`
|
|
- **2025-02-12** Assigned to s/c Health Subcommittee `referral-committee`
|
|
- **2025-02-12** P2C, ref. to Health Committee `referral-committee`
|
|
- **2025-03-12** Placed on s/c cal Health Subcommittee for 3/19/2025
|
|
- **2025-03-19** Placed on cal. Health Committee for 3/25/2025
|
|
- **2025-03-19** Rec for pass if am by s/c ref. to Health Committee `referral-committee`
|
|
- **2025-03-25** Action def. in Health Committee to 4/1/2025
|
|
- **2025-03-26** Placed on cal. Health Committee for 4/1/2025
|
|
- **2025-04-01** Rec. for pass. if am., ref. to Calendar & Rules Committee `committee-passage-favorable`
|
|
- **2025-04-02** Placed on cal. Calendar & Rules Committee for 4/3/2025
|
|
- **2025-04-03** H. Placed on Regular Calendar for 4/7/2025
|
|
- **2025-04-07** Passed Senate, Ayes 27, Nays 4 `passage`
|
|
- **2025-04-07** Amendment withdrawn. (Amendment 1 - SA0095)
|
|
- **2025-04-07** Senate substituted House Bill for companion Senate Bill. `substitution`
|
|
- **2025-04-07** Received from House, Passed on First Consideration `introduction`
|
|
- **2025-04-07** Engrossed; ready for transmission to Sen. `receipt`
|
|
- **2025-04-07** Passed H., as am., Ayes 92, Nays 1, PNV 0 `passage`
|
|
- **2025-04-07** Sponsor(s) Added. `sponsorship`
|
|
- **2025-04-07** H. adopted am. (Amendment 1 - HA0252) `amendment-passage`
|
|
- **2025-04-08** Enrolled; ready for sig. of H. Speaker. `enrolled`
|
|
- **2025-04-10** Signed by H. Speaker `passage`
|
|
- **2025-04-14** Signed by Senate Speaker `passage`
|
|
- **2025-04-16** Transmitted to Governor for his action. `executive-receipt`
|
|
- **2025-04-24** Signed by Governor. `executive-signature`
|
|
- **2025-04-28** Effective date(s) 07/01/2025
|
|
- **2025-04-28** Pub. Ch. 295
|
|
|
|
## Source
|
|
|
|
OpenStates / OpenCivicData bulk snapshot [2026-07-01](https://data.openstates.org/daily/2026-07-01/public.pgdump); origin `ocd-bill/7b282135-c886-44b0-bad3-76758bbbc006`. Confidence: reported (aggregated from official Tennessee legislature records).
|
|
|